Risk prediction model for cardiovascular diseases in adults initiating pharmacological treatment for attention-deficit/hyperactivity disorder

HIGHLIGHTS

• who: Maja Dobrosavljevic u200d u200d and collaborators from the School of, of Oxford, Oxford, UK have published the paper: Risk prediction model for cardiovascular diseases in adults initiating pharmacological treatment for attention-deficit/hyperactivity disorder, in the Journal: (JOURNAL) of 10/04/2022
• what: The model showed acceptable overall discrimination (C index=0.72, 95% CI 0.70 to 0.74) and calibration (Brier score=0.008). The authors aimed to develop a 2-u00adyear risk prediction model of CVDs in adults initiating ADHD pharmacological treatment using largescale data from population-u00adbased health registers from . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.